Regarding the contribution of FAK to the acquisition of cancer stem cell (CSC) attributes, Fan et al. [161] were able to show that increased FAK expression caused by promotor hypomethylation led to the expression of stem cell markers in liver carcinoma cell lines. Here, PTK2 is linked to hepatocellular carcinoma.